|
|
4321, Hartwick Road
College Park, MD 20740 USA
phone:301.469.5112
fax:301. 469. 9085
|
|
| Symbol |
private |
| Founded |
1991 |
| Employees |
40 |
|
|
| biomedicalenterprisesinc.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Minimally invasive orthopaedic instrumentation and implants. |
|
| Management |
| Alfredo Zarate, MD, President/CEO; Daniel Marx, financial advisory and business consultancy; Juan C Romero, MD, prolific researcher; George Wilcox, Managing Director |
| |
|
|
| |
|
| Keywords |
| venous, hemodialysis, needle dialysis, catheters, infections |
|
|
|
| Description |
|
BioMedical Enterprises, Inc. (BME) is a medical device company that addresses the changing needs in musculoskeletal medicine. BME focuses on minimally invasive orthopaedic instrumentation and implants that elicit a biologic response. BME's focus on memory metal internal fixation implants is changing the shape of orthopaedic medicine. |
|
| Products / Services |
The Company's BoneHOGTM: Bone and Marrow Collection System provides minimally invasive instrument to harvest and transplant bone for spinal and long bone fusion. The OSStapleTM/OSSPlateTM: Dynamic Compression implant consists of staples and plates that have memory, apply fixation forces and can be adjusted in the patient to reduce fractures and stimulate bone. Their most recent product is the OSSArc, an enhancement of the OSStaple. The OSSArc allows the surgeon to secure the legs of the implant parallel to the osteotomy or fusion interface while its unique sloping back creates a low profile construct that minimizes any potential soft tissue irritation by reducing the implant's prominence.
|
|
| Technology / Differentiation |
| BME's strategy is focused on minimally invasive orthopaedic instrumentation and implants that elicit a biologic response. They specialize in residual compression implants consisting of unique staples and plates that use osteosythesis through memory to apply fixation forces that can be adjusted in the patient to reduce fractures and stimulate bone healing. |
|
| Market / Customers |
Market analysts have predicted strong growth in the high-end orthopedic implant market as the baby-boomer generation continues to age. The global demographic trends of aging and obesity are expected to spur the rise in orthopedic implants in the coming years.
|
|
| Status |
| In October 2007, the FDA gave 510(k) marketing clearance to the OSSpine(TM) for use in anterior fixation of the cervical spine to provide enhanced biomechanical stability & bone graft retention. The patent-pending OSSpine(TM) builds on the extremity bone fusion success of BME's OSStaple(TM) and OSSplate(TM), and joins the Step OSStaple(TM) and the OSSArc(TM) |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members